摘要
目的:对2型糖尿病合并肺部感染患者在临床治疗中应用头孢哌酮舒巴坦联合左氧氟沙星取得的临床效果进行分析。方法:收治2型糖尿病合并肺部感染患者86例,平分两组。对照组给予头孢哌酮舒巴坦治疗,观察组在此基础上联合左氧氟沙星进行治疗,对两组患者的临床效果进行分析。结果:观察组的细菌清除率82.3%,显著高于对照组的46.8%(P<0.05)。观察组患者治疗总有效率95.3%,显著高于对照组的83.7%(P<0.05)。结论:2型糖尿病合并肺部感染患者应用头孢哌酮舒巴坦联合左氧氟沙星进行治疗,其临床不良反应较小,细菌清除率较高,效果显著。
Objective:To analyze the clinical effect of cefoperazone sulbactam combined with levofloxacin in the treatment of patients with type2diabetes complicated with pulmonary infection.Methods:86patients with type2diabetes complicated with pulmonary infection were selected.They were randomly divided into the two groups on average.The control group was treated with cefoperazone sulbactam.The observation group was treated with levofloxacin on the basis of the control group.The clinical effect of the two groups was analyzed.Results:The bacterial clearance rate of the observation group was82.3%,which was significantly higher than46.8%of the control group(P<0.05).The total effective rate of the observation group was95.3%higher than83.7%of the control group(P<0.05).Conclusion:In patients with type2diabetes complicated with pulmonary infection treated with cefoperazone sulbactam combined with levofloxacin,the clinical adverse reaction is small,the bacterial clearance rate is high,and the effect is significant.
作者
刘成梅
Liu Chengmei(Yunnan Kunming Iron and Steel Hospital 650302)
出处
《中国社区医师》
2017年第15期18-19,共2页
Chinese Community Doctors
关键词
2型糖尿病
肺部感染
胰岛素
Type 2 diabetes mellitus
Pulmonary infection
Insulin
